The six major components of M-92, a new antibiotic complex produced by Micromonospora verruculosa MCRL 0404 showed a similar type of antimicrobial spectrum. Among these components, VA-2 exhibited the most potent antimicrobial activity, particularly significantly against some Gram-positive bacteria and Neisseria. VA-2 and BN-1 also exhibited marked inhibitory effects against L-forms of Staphylococcus aureus 209P and Mycoplasina. The MICs of VA-2, BA-4 and BN-1 were remarkably affected by the pH of the test medium, the inoculum size and the amount of horse serum added in the medium. By intraperitoneal administration, these components showed good protective effects in mice infected intraperitoneally with Staphylococcus aureus Smith. However, the protective effect decreased remarkably by other administration routes. In addition, components such as VA-2 and BN-1 exhibited cytotoxicity against HeLa S-3 cells in vitro and excellent in vivo antitumor activity against Ehrlich carcinoma.
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VA-2 possessed a high order of acute toxicity to mice [LD50: 1.9 mg/kg (i.p.); 1.8 mg/kg (i.v.)], but others were relatively less toxic.
M-92, a new antibiotic complex, was obtained from culture broth and mycelia of Micromonospora verruculosa1). As reported in the foregoing paper, this complex was separated into the six major components by silica gel column chromatography, respectively designated VA-2, BA-4, BA-5, BN-1, BN-2 and BN-32). Those components obtained as reddish violet to blue amorphous powder are acidic or weakly acidic in nature and are considered to possess a quinoid structure judging from their physicochemical properties. The present paper is concerned with in vitro antimicrobial spectra, influences of medium pH, inoculum size and serum on the antibacterial activity, and protective effects against experimental bacterial infection by these components. In addition, cytotoxity on HeLa S-3 cells (in vitro), antitumor activity against Ehrlich carcinoma (in vivo) and acute toxicity in mice are also involved.
Materials and Methods
Antibiotics M-92 components were prepared as described in the preceding papers1,2). Antibiotic solutions for in vitro or in vivo test were prepared by dissolving the antibiotics in a small quantity of dimethylsulfoxide followed by dilution with sterile deionized water.
Determination of Minimum Inhibitory Concentration The minimum inhibitory concentration (MIC) of each antibiotic component was determined by the two-fold serial agar dilution method. The test organisms are those maintained in the stock culture collection of our laboratory.
Antibacterial and Antifungal Activity: One loopful of the culture suspension (106 cells/ml) of test organisms, except for Mycobacterium, was streaked on an assay plate containing the antibiotic, and the plates were incubated as follows: bacteria, at 37°C for 18 hours; fungi, at 27°C for 2 -7 days. MIC OF ANTIBIOTICS NOV. 1982 was determined as the lowest concentration at which the visible growth of the test organism was completely inhibited. Anti-L-form Activity: The L-forms were induced from Staphylococcus aureus 209P JC-1 by the penicillin-disc method on L-form agar3) (3.7 % brain heart infusion broth, 5 % NaCl, 1 % agar and 10 % horse serum). The stable L-form strain L-PG-412 was obtained by 10 transfers on the L-form agar supplemented with 5 units/ml of benzyl penicillin. The strain did not revert to the parent bacterial form during about 10 transfers on L-form agar containing no benzyl penicillin. On the contrary, the unstable L-form L-PG-212 reverted to the parent form on the L-form agar containing no benzyl penicillin. These L-forms were positive for coagulase production and resistant to penicillins. MICs of benzyl penicillin against these L-forms were 25 -100 units/ml. The stable L-form was cultured in the L-liquid culture medium4) (3.7 % brain heart infusion broth, 5 % NaCl and 10 % horse serum), while the unstable Lform was cultured in the L-liquid culture medium supplemented with 5 units/ml of benzyl penicillin. For the source of inoculum, these organisms were incubated for 3 days at 37°C and 0.01 ml of the cell culture (108 cells/ml) was dropped on the assay plate. The plates were sealed with vinyl-tape and kept standing at 37°C for 3 days. L-Form colonies grown on the plate were observed under a light microscope. The lowest concentration at which an antibiotic completely inhibited the growth of colonies was regarded as the MIC of this antibiotic.
Antimycoplasmal Activity: Mycoplasmas were cultured in the liquid medium5) [2.1 % PPLO broth (Difco) 70 ml, fresh horse serum 20 ml, 25 % fresh yeast extract 10 ml, thallium acetate 50 mg and benzyl penicillin (Na) 50,000 units in 100 ml (pH 7.6-7.8)]. After incubation at 37°C for about 3 days, the culture was used as the inoculum source. The antibiotic was diluted with the solid medium6) [3.7 PPLO agar (Difco) 70 ml, fresh horse serum 20 ml and 25% fresh yeast extract 10 ml]. A small quantity (0.01 ml) of the cell culture (106 ~ 107 cells/ml) was dropped on the assay plate. Plates were sealed with vinyl-tape and incubated at 37°C for 7 days. Colonies grown on the plates were observed under a light microscope.
Influence of Various Factors on MIC
The influence of various factors on the MIC of an antibiotic was examined by the two-fold serial broth dilution method. To assess the influence of medium pH, pH values of the medium were adjusted by 1 N HCl or I N NaOH. The influence of serum on MIC was examined by the volume of horse serum added in the medium. A small quantity (0.1 ml) of the culture suspension was added into 2 ml of the assay broth containing an antibiotic and the broth was incubated at 37'C for 18 hours.
Mouse Protection Test from Experimental Bacterial Infection
Male ddY mice aged 4 weeks, weighing 1921 g were used. An overnight culture of Staphylococcus aureus Smith in Trypto-soy broth (Eiken) at 37°C was suspended in 5 % bacteriological mucin (ICN Pharmaceuticals, Inc.) solution. The volume of 100 x LD,, of the above suspension was used to infect the mice intraperitoneally.
The protective effect (ED,,) was estimated from the survival ratio for 7 days.
Cytotoxic Test on HeLa S-3 Cells About 3 x 10° cells of HeLa S-3 were incubated in the culture tube with 1 ml of the medium. After incubation for 24 hours at 37°C, the old medium was replaced by fresh medium containing the antibiotic and the incubation was continued for 3 days. Cytological changes were determined by the microscopic observation of the cell stained with May-Gruenwald Giemsa solution.
Anti-Ehrlich Activity Test in Mice Female ICR mice weighing 19-22 g were used. For Ehrlich ascites tumor, antitumor activity was evaluated by comparing the mean survival day of the treated mice with that of non-treated mice, i.e. by percentage increase in life span (ILS %). For Ehrlich solid tumor, antitumor activity was evaluated in terms of the inhibitory ratio of the tumor growth at 10 days after implantation by comparing the mean tumor weight in the treated mice with that of non-treated mice, i.e. by percentage of inhibitory ratio.
Acute Toxicity Test in Mice Male ddY mice aged 4 weeks, weighing 19-21 g were used. LD50 values were estimated from the lethal ratio for 7 days after a single intraperitoneal or intravenous administration. a) The MIC was determined by broth dilution method. b) Medium I: Heart infusion agar . IL: Brain heart infusion agar. III: Kirchner medium. IV: Brain heart infusion agar supplemented with 10% horse serum. V: Heart infusion agar supplemented with 1 % glycerin. VI: Sabouraud agar. Icg/ml, Neisseria at 0.00001-0.001 Ng/ml, L-forms of S. aureus at 0.000156 µg/ml and Mycoplasma at 0.0000313 -0.002 tag/ml. Moreover, VA-2 inhibited the growth of a number of drug resistant strains as well as those of the sensitive strains.
VA-2 showed weak antifungal activity as well.
Influence of Medium pH, Inoculum Size and Serum on Antibacterial Activity
The influence of medium pH, inoculum size and serum on the antibacterial activities of VA-2, BA-4 and BN-1 are shown in Table 3 . The MIC of the component was dependent upon the pH of Medium VII: Brain heart infusion broth supplemented with 5 % NaCl, 10% horse serum and 1 % agar. VIII: Medium VII supplemented with 5 units/ml of PC-G(Na). IX: PPLO agar supplemented with 20% horse serum and 10% yeast extract solution (25%). Cytotoxic Activity
The cytotoxic activities of M-92 components on HeLa cells are shown in Table 5 . The cytological changes of HeLa S-3 cells were observed at concentrations higher than 4 jig/ml of all components of M-92. VA-2 exhibited a significant cytotoxic activity and the minimum degenerating concentration was 0.001 jig/ml.
Anti-Ehrlich Activity in Mice The effect of M-92 components on Ehrlich carcinoma (ascites form) are shown in Table 6 . a) The antibiotic was intraveneously administered once daily for 5 days, starting 24 hours after the implantation. b) Inhibition ratio (%)=(I -mean tumor weight of the treated group/mean tumor weight of the non-treated group) x 100. a) The figures in the parenthesis=number of died mice/number of mice used. Table 7 shows the inhibitory effect of M-92 components on the growth of Ehrlich carcinoma (solid form) implanted in mice. By intravenous administration once daily for 5 days, VA-2 and BN-1 inhibited tumor growth. VA-2 at a dose of 0.5 and 0.25 mg/kg/day, and BN-1 at 10 mg/kg/day inhibited growth with the inhibitory ratio of greater than 80%.
Acute Toxicity
The acute toxicities of M-92 components are shown in Table 8 . VA-2 possessed a high order of toxicity in mice and the LD50s were 1.9 mg/kg and 1.8 mg/kg by i.p. and i.v. administration, respectively. LD,,s of BA-4 and BN-1 by intravenous injection were found to be 43.5 and 91 mg/kg, respectively, but those of BA-5, BN-2 and BN-3 were > 100 mg/kg, suggesting the lower toxicities of these components than VA-2.
